International Journal of Hematology and Oncology 2021, Vol 31, Num 1 Page(s): 019-027
Clinical Outcomes of CML Patients After Delayed Start of Nilotinib Treatment

Erna ISLAMAGIC1, Azra HASIC1, Sabira KURTOVIC2, Damir SULJEVIC1, Mirza KOZARIC3, Izet EMINOVIC1, Amina KURTOVIC-KOZARIC4

1University of Sarajevo, Faculty of Science, Department of Biochemistry and Physiology, BOSNIA and HERZEGOWINA
2Clinical Center of the University of Sarajevo, Department of Hematology, BOSNIA and HERZEGOWINA
3Clinical Center of the University of Sarajevo, Department of Obstetrics and Gynecology, BOSNIA and HERZEGOWINA
4Clinical Center of the University of Sarajevo, Department of Pathology, Cytology and Human Genetics, Sarajevo, BOSNIA and HERZEGOWINA